Biosimilars for the Treatment of Chronic Inflammatory Diseases: A Systematic Review of Published Evidence.

ABSTRACT:

Background

Clinicians are required to assimilate, critically evaluate, and extrapolate information to support appropriate use of biosimilars across indications.

Objectives

The objective of this study was to systematically collate all published data in order to assess the weight (quantity and quality) of available evidence for each molecule and inform and support healthcare decision-making in chronic inflammatory diseases.

Methods

MEDLINE^®, EMBASE^®, and ISI Web of Science^® were searched to September 2015. Selected conference proceedings were searched from 2012 to July 2015. Studies disclosing biosimilars with unique identifiers were categorized by originator, study type, and indication. Risk of bias assessments were performed. Intended

SUBMITTER: Jacobs I 

PROVIDER: S-EPMC5126192 | biostudies-literature | 2016 Dec

REPOSITORIES: biostudies-literature